NXTS.US Nexentis Technologies Inc.

Basic Materials Agricultural Inputs USA Stocks
2.21 USD
Close of Nov 15, 2026
1.93 117.25
Market cap
USD 1.05M
P/E
-
P/B
0.55x
ROE
-1,860.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NXTS.US undervalued?

Graham number

The Graham number of Nexentis Technologies Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nexentis Technologies Inc. fundamental analysis

No fundamental analysis for Nexentis Technologies Inc. yet.

Nexentis Technologies Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nexentis Technologies Inc.

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational ch…

Full company profile